Senior insider sale
Chief Development Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$1.81M
50.56K shares
What this filing means
YELESWARAM KRISHNASWAMY plans to sell 50.56K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $1.81M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/17/2026ACC: 0001950047-26-003609
Officer· Chief Development Officer
Since Feb 2026
50.56K
Shares to sell
$1.81M
Approx. market value
20.23K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
2/9/2025
20.23KTotal acquired20.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/9/2025 | Founders Shares N/A | 20.23K | — |
| Total | 20.23K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
10.20K
Market value
$357.8K
4/14/2026
—Completed
Units to sell
9.16K
Market value
$320.5K
4/13/2026
—Completed
Units to sell
500.00
Market value
$17.5K
4/10/2026
—Completed
Units to sell
360.00
Market value
$12.6K
4/8/2026
—Completed
Units to sell
10.12K
Market value
$303.4K
3/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
20.23K
Market value
$799.7K
4/17/2026
Total
Units
50.56K
Value
$1.81M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 10.20K | $357.8K | — | Completed |
4/13/2026 | 9.16K | $320.5K | — | Completed |
4/10/2026 | 500.00 | $17.5K | — | Completed |
4/8/2026 | 360.00 | $12.6K | — | Completed |
3/25/2026 | 10.12K | $303.4K | — | Completed |
| Planned — Approximate Date | ||||
4/17/2026 | 20.23K | $799.7K | NASDAQ | Planned |
| Total | 50.56K | $1.81M | ||